{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:06:06Z","timestamp":1791644766316,"version":"4.3.4"},"reference-count":94,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 BX004893"],"award-info":[{"award-number":["I01 BX004893"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 CX002015"],"award-info":[{"award-number":["I01 CX002015"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0579"],"award-info":[{"award-number":["W81XWH-20-1-0579"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0820"],"award-info":[{"award-number":["W81XWH-20-1-0820"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY026174"],"award-info":[{"award-number":["R01EY026174"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R61EY032468"],"award-info":[{"award-number":["R61EY032468"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2021,3,31]]},"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:p>Dry eye disease (DED) is a multifactorial disease that manifests in patients with a variety of symptoms and signs such as ocular pain, visual issues, rapid tear evaporation and\/or decreased tear production. It is a global health problem and is the leading cause of optometry and ophthalmology clinic visits. The mainstay therapy for DED is artificial tears (ATs), which mimics tears and improves tear stability and properties. ATs have been found to improve symptoms and signs of disease in all DED subtypes, including aqueous deficient DED and evaporative DED. However, given the heterogeneity of DED, it is not surprising that ATs are not effective in all patients. When AT fails to relieve symptoms and\/or signs of DED, it is critical to identify the underlying contributors to disease and escalate therapy appropriately. This includes underlying systemic diseases, meibomian gland dysfunction, anatomical abnormalities and neuropathic dysfunction. Thus, this review will discuss the benefits and limitations of ATs and review conditions when escalation of therapy should be considered in DED.<\/jats:p>","DOI":"10.1136\/bmjophth-2020-000697","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T12:55:30Z","timestamp":1617886530000},"page":"e000697","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":62,"title":["Dry eye: why artificial tears are not always the answer"],"prefix":"10.1136","volume":"6","author":[{"given":"Minji","family":"Kim","sequence":"first","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghoon","family":"Lee","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9507-6635","authenticated-orcid":false,"given":"Divy","family":"Mehra","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, Florida, USA"},{"name":"Ophthalmology, Miami Veterans Affairs Medical Center, Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso L","family":"Sabater","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3026-6155","authenticated-orcid":false,"given":"Anat","family":"Galor","sequence":"additional","affiliation":[{"name":"Bascom Palmer Eye Institute, University of Miami, Miami, Florida, USA"},{"name":"Ophthalmology, Miami Veterans Affairs Medical Center, Miami, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"2025090109424868000_6.1.e000697.1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II report executive summary","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"key":"2025090109424868000_6.1.e000697.2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1586\/17469899.2015.1061431","article-title":"Understanding the true burden of dry eye disease","volume":"10","author":"Galor","year":"2015","journal-title":"Expert Rev Ophthalmol"},{"key":"2025090109424868000_6.1.e000697.3","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"key":"2025090109424868000_6.1.e000697.4","doi-asserted-by":"publisher","DOI":"10.1097\/00006324-199708000-00023"},{"key":"2025090109424868000_6.1.e000697.5","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181f7f363"},{"key":"2025090109424868000_6.1.e000697.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.11.030"},{"key":"2025090109424868000_6.1.e000697.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(03)00462-7"},{"key":"2025090109424868000_6.1.e000697.8","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.ophtha.2015.10.011","article-title":"Long-Term natural history of dry eye disease from the patient's perspective","volume":"123","author":"Lienert","year":"2016","journal-title":"Ophthalmology"},{"key":"2025090109424868000_6.1.e000697.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00218-6"},{"key":"2025090109424868000_6.1.e000697.10","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.118.9.1264"},{"key":"2025090109424868000_6.1.e000697.11","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S5555"},{"key":"2025090109424868000_6.1.e000697.12","doi-asserted-by":"publisher","DOI":"10.1097\/00055735-200108000-00013"},{"key":"2025090109424868000_6.1.e000697.13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/eye.2014.263","article-title":"Neuropathic ocular pain: an important yet underevaluated feature of dry eye","volume":"29","author":"Galor","year":"2015","journal-title":"Eye"},{"key":"2025090109424868000_6.1.e000697.14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/ICL.0000000000000249","article-title":"Characteristics of ocular pain complaints in patients with idiopathic dry eye symptoms","volume":"43","author":"Kalangara","year":"2017","journal-title":"Eye Contact Lens"},{"key":"2025090109424868000_6.1.e000697.15","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10819"},{"key":"2025090109424868000_6.1.e000697.16","first-page":"71","article-title":"The pathophysiology, diagnosis, and treatment of dry eye disease","volume":"112","author":"Messmer","year":"2015","journal-title":"Dtsch Arztebl Int"},{"key":"2025090109424868000_6.1.e000697.17","article-title":"Dry eye management: targeting the ocular surface microenvironment","volume":"18","author":"Zhang","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2025090109424868000_6.1.e000697.18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00004397-199403410-00008","article-title":"Systemic diseases associated with dry eye","volume":"34","author":"Fox","year":"1994","journal-title":"Int Ophthalmol Clin"},{"key":"2025090109424868000_6.1.e000697.19","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1167\/iovs.14-16337","article-title":"The impact of conjunctivochalasis on dry eye symptoms and signs","volume":"56","author":"Chhadva","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2025090109424868000_6.1.e000697.20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/ICO.0000000000000786","article-title":"Impact of eyelid laxity on symptoms and signs of dry eye disease","volume":"35","author":"Chhadva","year":"2016","journal-title":"Cornea"},{"key":"2025090109424868000_6.1.e000697.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.10.001"},{"key":"2025090109424868000_6.1.e000697.22","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.2147\/OPTH.S256351","article-title":"A comparison of efficacy and safety of two lipid-based lubricant eye drops for the management of evaporative dry eye disease","volume":"14","author":"Jerkins","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"2025090109424868000_6.1.e000697.23","unstructured":"Allergan . 2001 annual report. Irvine, CA; 2001: 23."},{"key":"2025090109424868000_6.1.e000697.24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3341\/kjo.2014.28.2.115","article-title":"Current practice pattern for dry eye patients in South Korea: a multicenter study","volume":"28","author":"Song","year":"2014","journal-title":"Korean J Ophthalmol"},{"key":"2025090109424868000_6.1.e000697.25","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X132640"},{"key":"2025090109424868000_6.1.e000697.26","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-004-0077-2"},{"key":"2025090109424868000_6.1.e000697.27","article-title":"Over the counter (otc) artificial tear drops for dry eye syndrome","volume":"2","author":"Pucker","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2025090109424868000_6.1.e000697.28","unstructured":"U.S. Food and Drug Administration . Ophthalmic drug products for over-the-counter human use; 2019."},{"key":"2025090109424868000_6.1.e000697.29","unstructured":"Horton M , Horton M , Reinhard E . Master the maze of artificial tears. Available: https:\/\/www.reviewofoptometry.com\/article\/master-the-maze-of-artificial-tears"},{"key":"2025090109424868000_6.1.e000697.30","doi-asserted-by":"publisher","DOI":"10.1097\/01.icl.0000181819.63425.a6"},{"key":"2025090109424868000_6.1.e000697.31","doi-asserted-by":"publisher","DOI":"10.1007\/BF02853166"},{"key":"2025090109424868000_6.1.e000697.32","doi-asserted-by":"publisher","DOI":"10.1007\/BF02169786"},{"key":"2025090109424868000_6.1.e000697.33","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2010.01.003"},{"key":"2025090109424868000_6.1.e000697.34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/jop.2016.0086","article-title":"A randomized multicenter study comparing 0.1%, 0.15%, and 0.3% sodium hyaluronate with 0.05% cyclosporine in the treatment of dry eye","volume":"33","author":"Park","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"key":"2025090109424868000_6.1.e000697.35","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2147\/OPTH.S69486","article-title":"Clinical utility of 3% diquafosol ophthalmic solution in the treatment of dry eyes","volume":"9","author":"Koh","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"2025090109424868000_6.1.e000697.36","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-301448"},{"key":"2025090109424868000_6.1.e000697.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)00513-8"},{"key":"2025090109424868000_6.1.e000697.38","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-199603000-00003"},{"key":"2025090109424868000_6.1.e000697.39","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.86.8.879"},{"key":"2025090109424868000_6.1.e000697.40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.clae.2017.07.007","article-title":"Can the optimum artificial tear treatment for dry eye disease be predicted from presenting signs and symptoms?","volume":"41","author":"Essa","year":"2018","journal-title":"Cont Lens Anterior Eye"},{"key":"2025090109424868000_6.1.e000697.41","doi-asserted-by":"publisher","DOI":"10.1097\/00006324-199701000-00014"},{"key":"2025090109424868000_6.1.e000697.42","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1089\/jop.2017.0052","article-title":"Relevance of lipid-based products in the management of dry eye disease","volume":"33","author":"Garrigue","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"key":"2025090109424868000_6.1.e000697.43","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.2147\/OPTH.S70623","article-title":"Effects of Systane(\u00ae) Balance on noninvasive tear film break-up time in patients with lipid-deficient dry eye","volume":"8","author":"Aguilar","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"2025090109424868000_6.1.e000697.44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/ICO.0b013e31821b71e6","article-title":"Effectiveness of artificial tears in the management of evaporative dry eye","volume":"31","author":"McCann","year":"2012","journal-title":"Cornea"},{"key":"2025090109424868000_6.1.e000697.45","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181b11648"},{"key":"2025090109424868000_6.1.e000697.46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/jop.2015.0054","article-title":"Comparison of the anti-inflammatory effects of artificial tears in a rat model of corneal scraping","volume":"32","author":"Daull","year":"2016","journal-title":"J Ocul Pharmacol Ther"},{"key":"2025090109424868000_6.1.e000697.47","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0000000000000020"},{"key":"2025090109424868000_6.1.e000697.48","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10792-014-9969-x","article-title":"The role and treatment of inflammation in dry eye disease","volume":"34","author":"Yagci","year":"2014","journal-title":"Int Ophthalmol"},{"key":"2025090109424868000_6.1.e000697.49","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(03)00326-X"},{"key":"2025090109424868000_6.1.e000697.50","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2006.02.004"},{"key":"2025090109424868000_6.1.e000697.51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/09273948.2017.1341988","article-title":"The use of topical corticosteroids for treatment of dry eye syndrome","volume":"27","author":"Cutolo","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"2025090109424868000_6.1.e000697.52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2003.10.036"},{"key":"2025090109424868000_6.1.e000697.53","doi-asserted-by":"publisher","DOI":"10.1097\/ICL.0b013e31822563be"},{"key":"2025090109424868000_6.1.e000697.54","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e318158f6dc"},{"key":"2025090109424868000_6.1.e000697.55","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.ophtha.2015.08.001","article-title":"Lifitegrast ophthalmic solution 5.0% versus placebo for treatment of dry eye disease: Results of the randomized phase iii opus-2 study","volume":"122","author":"Tauber","year":"2015","journal-title":"Ophthalmology"},{"key":"2025090109424868000_6.1.e000697.56","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31818d3846"},{"key":"2025090109424868000_6.1.e000697.57","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/j.1755-3768.1994.tb02792.x","article-title":"Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sj\u00f6gren's syndrome","volume":"72","author":"G\u00fcnd\u00fcz","year":"1994","journal-title":"Acta Ophthalmol"},{"key":"2025090109424868000_6.1.e000697.58","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1527-x"},{"key":"2025090109424868000_6.1.e000697.59","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1542-0124(12)70113-1","article-title":"Punctal plugs in the management of dry eyes","volume":"2","author":"Baxter","year":"2004","journal-title":"Ocul Surf"},{"key":"2025090109424868000_6.1.e000697.60","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2002.003889"},{"key":"2025090109424868000_6.1.e000697.61","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200310001-00004"},{"key":"2025090109424868000_6.1.e000697.62","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.ico.0000208813.17367.0c","article-title":"Efficacy of topical cyclosporine 0.05% in the treatment of dry eye associated with graft versus host disease","volume":"25","author":"Rao","year":"2006","journal-title":"Cornea"},{"key":"2025090109424868000_6.1.e000697.63","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jtos.2019.01.009","article-title":"Efficacy of autologous serum tears for treatment of neuropathic corneal pain","volume":"17","author":"Aggarwal","year":"2019","journal-title":"Ocul Surf"},{"key":"2025090109424868000_6.1.e000697.64","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7340"},{"key":"2025090109424868000_6.1.e000697.65","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1159\/000505630","article-title":"Autologous serum eye drops versus artificial tear drops for dry eye disease: a systematic review and meta-analysis of randomized controlled trials","volume":"63","author":"Wang","year":"2020","journal-title":"Ophthalmic Res"},{"key":"2025090109424868000_6.1.e000697.66","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.83.4.390"},{"key":"2025090109424868000_6.1.e000697.67","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703862"},{"key":"2025090109424868000_6.1.e000697.68","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s40123-017-0100-z","article-title":"Treatment of dry eye disease with autologous platelet-rich plasma: a prospective, interventional, non-randomized study","volume":"6","author":"Alio","year":"2017","journal-title":"Ophthalmol Ther"},{"key":"2025090109424868000_6.1.e000697.69","doi-asserted-by":"crossref","first-page":"875","DOI":"10.3109\/02713683.2015.1104362","article-title":"Plasma rich in growth factors for the treatment of ocular surface diseases","volume":"41","author":"Anitua","year":"2016","journal-title":"Curr Eye Res"},{"key":"2025090109424868000_6.1.e000697.70","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31820d86d6"},{"key":"2025090109424868000_6.1.e000697.71","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.exer.2016.08.012","article-title":"Prgf exerts more potent proliferative and anti-inflammatory effects than autologous serum on a cell culture inflammatory model","volume":"151","author":"Anitua","year":"2016","journal-title":"Exp Eye Res"},{"key":"2025090109424868000_6.1.e000697.72","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jtos.2014.12.002","article-title":"Meibomian glands and ocular surface inflammation","volume":"13","author":"Suzuki","year":"2015","journal-title":"Ocul Surf"},{"key":"2025090109424868000_6.1.e000697.73","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-305410"},{"key":"2025090109424868000_6.1.e000697.74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tox.2014.02.014","article-title":"One man's poison is another man's meat: using azithromycin-induced phospholipidosis to promote ocular surface health","volume":"320","author":"Liu","year":"2014","journal-title":"Toxicology"},{"key":"2025090109424868000_6.1.e000697.75","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2005.19.4.258"},{"key":"2025090109424868000_6.1.e000697.76","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4103\/ijo.IJO_1244_17","article-title":"Oral azithromycin and oral doxycycline for the treatment of meibomian gland dysfunction: a 9-month comparative case series","volume":"67","author":"De Benedetti","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"2025090109424868000_6.1.e000697.77","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1120672118817687","article-title":"Intense regulated pulse light for the meibomian gland dysfunction","volume":"30","author":"Karaca","year":"2020","journal-title":"Eur J Ophthalmol"},{"key":"2025090109424868000_6.1.e000697.78","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2020.106474","article-title":"Changes of tear lipid mediators after eyelid warming or thermopulsation treatment for meibomian gland dysfunction","volume":"151","author":"Ambaw","year":"2020","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"2025090109424868000_6.1.e000697.79","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1080\/09273948.2018.1522357","article-title":"Effectiveness of intraductal meibomian gland probing in addition to the conventional treatment in patients with obstructive meibomian gland dysfunction","volume":"27","author":"Incekalan","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"2025090109424868000_6.1.e000697.80","article-title":"Dry eye","volume":"379","author":"Clayton","year":"2018","journal-title":"N Engl J Med"},{"key":"2025090109424868000_6.1.e000697.81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132656","article-title":"Isotonic glycerol and sodium hyaluronate containing artificial tear decreases conjunctivochalasis after one and three months: a self-controlled, unmasked study","volume":"10","author":"Kiss","year":"2015","journal-title":"PLoS One"},{"key":"2025090109424868000_6.1.e000697.82","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/OPX.0b013e3182223573","article-title":"Evaluation of tear stability after surgery for conjunctivochalasis","volume":"88","author":"Hara","year":"2011","journal-title":"Optom Vis Sci"},{"key":"2025090109424868000_6.1.e000697.83","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4274\/tjo.35002","article-title":"Comparison of electrocoagulation and conventional medical drops for treatment of conjunctivochalasis: short-term results","volume":"48","author":"\u00c7a\u011flayan","year":"2018","journal-title":"Turk J Ophthalmol"},{"key":"2025090109424868000_6.1.e000697.84","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jcjo.2013.11.010","article-title":"Long-Term effects of pap on ocular surface in obstructive sleep apnea syndrome","volume":"49","author":"Acar","year":"2014","journal-title":"Can J Ophthalmol"},{"key":"2025090109424868000_6.1.e000697.85","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jtos.2019.10.002","article-title":"Floppy eyelid syndrome: a comprehensive review","volume":"18","author":"Salinas","year":"2020","journal-title":"Ocul Surf"},{"key":"2025090109424868000_6.1.e000697.86","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40123-020-00282-6","article-title":"Face Mask-Associated ocular irritation and dryness","volume":"9","author":"Moshirfar","year":"2020","journal-title":"Ophthalmol Ther"},{"key":"2025090109424868000_6.1.e000697.87","doi-asserted-by":"publisher","DOI":"10.3109\/08830185.2012.748052"},{"key":"2025090109424868000_6.1.e000697.88","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/ICL.0000000000000630","article-title":"Oral gabapentinoids and nerve blocks for the treatment of chronic ocular pain","volume":"46","author":"Small","year":"2020","journal-title":"Eye Contact Lens"},{"key":"2025090109424868000_6.1.e000697.89","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307094"},{"key":"2025090109424868000_6.1.e000697.90","article-title":"Photophobia: shared pathophysiology underlying dry eye disease, migraine and traumatic brain injury leading to central neuroplasticity of the trigeminothalamic pathway","author":"Diel","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"2025090109424868000_6.1.e000697.91","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s13760-019-01156-w","article-title":"Is gabapentin effective in dry eye disease and neuropathic ocular pain?","volume":"121","author":"Ongun","year":"2021","journal-title":"Acta Neurol Belg"},{"key":"2025090109424868000_6.1.e000697.92","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajoc.2020.100809","article-title":"Periorbital botulinum toxin A improves photophobia and sensations of dryness in patients without migraine: case series of four patients","volume":"19","author":"Venkateswaran","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"2025090109424868000_6.1.e000697.93","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/ner.13146","article-title":"Transcutaneous electrical nerve stimulation for the long-term treatment of ocular pain","volume":"23","author":"Zayan","year":"2020","journal-title":"Neuromodulation"},{"key":"2025090109424868000_6.1.e000697.94","first-page":"1","article-title":"Transcutaneous electrical nerve stimulation for facial pain","volume":"35","author":"Zayan","year":"2020","journal-title":"Prog Neurol Surg"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2020-000697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:43:06Z","timestamp":1756744986000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2020-000697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,4,8]]},"published-print":{"date-parts":[[2021,4]]}},"alternative-id":["10.1136\/bmjophth-2020-000697"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2020-000697","relation":{},"ISSN":["2397-3269"],"issn-type":[{"value":"2397-3269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}